1. Home
  2. MRTN vs GYRE Comparison

MRTN vs GYRE Comparison

Compare MRTN & GYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRTN
  • GYRE
  • Stock Information
  • Founded
  • MRTN 1946
  • GYRE 2002
  • Country
  • MRTN United States
  • GYRE United States
  • Employees
  • MRTN N/A
  • GYRE N/A
  • Industry
  • MRTN Trucking Freight/Courier Services
  • GYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • MRTN Industrials
  • GYRE Health Care
  • Exchange
  • MRTN Nasdaq
  • GYRE Nasdaq
  • Market Cap
  • MRTN 1.1B
  • GYRE 990.4M
  • IPO Year
  • MRTN 1986
  • GYRE N/A
  • Fundamental
  • Price
  • MRTN $13.26
  • GYRE $8.88
  • Analyst Decision
  • MRTN Buy
  • GYRE
  • Analyst Count
  • MRTN 2
  • GYRE 0
  • Target Price
  • MRTN $19.00
  • GYRE N/A
  • AVG Volume (30 Days)
  • MRTN 487.0K
  • GYRE 209.4K
  • Earning Date
  • MRTN 04-16-2025
  • GYRE 05-19-2025
  • Dividend Yield
  • MRTN 1.81%
  • GYRE N/A
  • EPS Growth
  • MRTN N/A
  • GYRE N/A
  • EPS
  • MRTN 0.26
  • GYRE 0.05
  • Revenue
  • MRTN $937,188,000.00
  • GYRE $105,757,000.00
  • Revenue This Year
  • MRTN $1.94
  • GYRE $22.01
  • Revenue Next Year
  • MRTN $9.32
  • GYRE $88.14
  • P/E Ratio
  • MRTN $51.00
  • GYRE $184.70
  • Revenue Growth
  • MRTN N/A
  • GYRE N/A
  • 52 Week Low
  • MRTN $12.52
  • GYRE $6.11
  • 52 Week High
  • MRTN $19.26
  • GYRE $19.00
  • Technical
  • Relative Strength Index (RSI)
  • MRTN 44.36
  • GYRE 51.54
  • Support Level
  • MRTN $12.62
  • GYRE $7.03
  • Resistance Level
  • MRTN $13.50
  • GYRE $8.44
  • Average True Range (ATR)
  • MRTN 0.56
  • GYRE 1.12
  • MACD
  • MRTN 0.02
  • GYRE 0.23
  • Stochastic Oscillator
  • MRTN 52.11
  • GYRE 92.33

About MRTN Marten Transport Ltd.

Marten Transport Ltd is a temperature-sensitive truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. It operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services.

About GYRE Gyre Therapeutics Inc.

Gyre Therapeutics Inc is a biopharmaceutical company headquartered in San Diego, CA, that is primarily focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis), formerly known as Nonalcoholic Steatohepatitis (NASH)) in the United States. In the United States, Hydronidone is currently being evaluated for the treatment of liver fibrosis across a broad spectrum of chronic liver diseases under an active Investigational New Drug (IND) application. Gyre is also advancing a diverse pipeline in China through a controlling interest in the Beijing Continent, including pirfenidone, F573, F528, and F230.

Share on Social Networks: